NCT03980301

Brief Summary

Hepatitis C virus is one of the virulent viruses

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2020

Completed
Last Updated

November 3, 2020

Status Verified

October 1, 2020

Enrollment Period

1.7 years

First QC Date

June 6, 2019

Last Update Submit

October 31, 2020

Conditions

Hepatitis C

Outcome Measures

Primary Outcomes (1)

  • the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies

    the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies by us

    within 6 months

Interventions

ultrasoundDIAGNOSTIC_TEST

screening of pregnant women with hepatitis c virus received treatment in first trimester for congenital anomalies

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women with hepatitis C virus
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women with hepatitis C virus received treatment during first trimester

You may qualify if:

  • Pregnant women with hepatitis C virus received treatment during first trimester

You may not qualify if:

  • pregnant women with hepatitis C virus who didnot receive treatment during first trimester

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah

Giza, Egypt

Location

MeSH Terms

Conditions

Hepatitis C

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2019

First Posted

June 10, 2019

Study Start

October 11, 2018

Primary Completion

June 15, 2020

Study Completion

October 20, 2020

Last Updated

November 3, 2020

Record last verified: 2020-10

Locations

EG(1)